Italian scientists have claimed that the antibodies generated in mice against the novel coronavirus by their vaccine candidate have worked on human cells too, reported The Arab News.
Tests carried out at Rome infectious-disease Spallanzani Hospital found that the vaccine neutralized the virus in human cells, claimed as a first by Luigi Aurisicchio, the CEO of Takis (the firm developing it) since the vaccine development efforts began in the world.
Speaking to the Italian news agency ANSA, he said, “This is the most advanced stage of testing of a candidate created in Italy. Human tests are expected after this summer.”
After a single vaccination given to mice, they developed the antibodies that block the virus from infecting human cells. Two out of the five vaccine candidates were chosen, based on the best results.
While the vaccine candidates being developed around the world right now are based on the genetic material of DNA protein ‘spike’, this one uses ‘electroporation’ technique to help the vaccine break into the cells and activate the immune system, the Arab News reported. Scientists believe this makes their candidate particularly effective for generating the functional antibodies against ‘spike’ protein in the lung cells.
Dr Emanuele Marra from Takis was quoted as saying, “So far, the immunity generated by most of our five vaccine candidates has an effect on the virus. We expect even better results after the second vaccination.
Marra added that those vaccine candidates could adapt to COVID-19 evolutions and its mutations.
Out of the over 100 trials underway, eight are currently enrolling volunteers, with only three among them to have entered Phase 2. Others are still in the pre-clinical development stage.
A vaccine is vital in reducing the growing number of confirmed COVID-19 cases worldwide and will help tremendously in reducing the death rate of the disease.
(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)
(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)
We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.
Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.
The Quint is available on Telegram & WhatsApp too, click to join.